Towards Healthcare
Cold Plasma Market to Increase USD 11.14 Billion by 2034

Cold Plasma Market Evolution with 2025 Research Advances

According to market projections, the cold plasma sector is expected to grow from USD 2.92 billion in 2024 to USD 11.14 billion by 2034, reflecting a CAGR of 14.35%. The market is growing due to rising use in healthcare, food safety, and materials processing for sterilization and surface modification. Increasing demand for eco-friendly, non-thermal technologies further drives their adoption in Europe.

Content

  • Insight Code: 6063
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The cold plasma market is valued at USD 3.34 billion in 2025 and is on track to reach USD 11.14 billion by 2034, witnessing a steady CAGR of 14.35% during the forecast span.

Europe is currently leading the cold plasma market share 36%, due to the region strong adoption of advanced medical technologies and well-established healthcare infrastructure.

The cold plasma market includes 5 segments by application, by device type technology, by end-user, by business model revenue stream, and by region.

Key trends include the growth due to rising use in healthcare, food safety, and materials processing for sterilization and surface modification.

Yes, cold plasma is generally safe when applied correctly, as it is non-thermal and non-invasive, though professional guidance is recommended.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions